Brief Report
Incidence, mortality, and cost trends in nonventilator hospital-acquired pneumonia in medicaid beneficiaries, 2015-2019
- Karen K. Giuliano
- Dian Baker
- Madhuli Thakkar-Samtani
- Michael Glick
- Marcos I. Restrepo
- Frank A. Scannapieco
- Lisa J. Heaton
- Julie Frantsve-Hawley
AJIC: American Journal of Infection Control 51(2):p 227-230, February 2023. | DOI: 10.1016/j.ajic.2022.06.016
Nonventilator hospital-acquired pneumonia is associated with substantial morbidity, mortality, and costs during an episode of acute care. We examined NVHAP incidence, mortality, and costs of Medicaid beneficiaries over a 5-year period (2015-2019). Overall NVHAP incidence was 2.63 per 1,000 patient days, and mortality was 7.76%, with an excess cost per NVHAP case of $20,189.
Copyright © 2023 by the Association for Professionals in Infection Control and Epidemiology, Inc.